| |
| |
|
| Insider
Information: |
Lau Johnson Yiu Nam |
| Relationship: |
CEO and Chairman of th... |
| City: |
Charlotte |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
261,397 |
|
|
Indirect Shares
|
47,551 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
308,948 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Chelsea Therapeutics Internation... |
CHTP |
Director |
2012-06-04 |
11,000 |
2008-09-29 |
0 |
Premium* |
|
|
Athenex, Inc. |
ATNX |
CEO and Chairman of th... |
2023-05-05 |
250,397 |
2023-05-05 |
47,551 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
105 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATNX |
Athenex, Inc. |
See RemarksOfficer |
• • • |
2017-06-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,322,722 |
|
- |
|
| ATNX |
Athenex, Inc. |
See RemarksOfficer |
• • • |
2017-06-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
840,527 |
|
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • • |
2017-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
400,000 |
2,722,722 |
0 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • • |
2018-06-29 |
4 |
A |
$0.00 |
$0 |
I/I |
107,181 |
107,181 |
0 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • • |
2019-04-16 |
4 |
A |
$0.00 |
$0 |
D/D |
15,574 |
3,011,959 |
0 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • • |
2019-04-16 |
4 |
A |
$0.00 |
$0 |
I/I |
3,278 |
164,925 |
0 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • – |
2022-08-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
37,500 |
3,520,381 |
0 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
Director |
– • – |
2008-10-03 |
4 |
B |
$2.76 |
$2,760 |
D/D |
1,000 |
3,000 |
2.31 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • – |
2023-02-24 |
4 |
A |
$2.74 |
$4,359 |
D/D |
1,591 |
210,215 |
0 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • – |
2023-01-13 |
4 |
A |
$0.19 |
$4,360 |
D/D |
23,441 |
4,130,566 |
0 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • – |
2023-01-27 |
4 |
A |
$0.19 |
$4,360 |
D/D |
22,533 |
4,153,099 |
0 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • – |
2023-02-10 |
4 |
A |
$0.23 |
$4,360 |
D/D |
19,378 |
4,172,477 |
0 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • – |
2022-08-03 |
4 |
D |
$0.58 |
$5,302 |
D/D |
(9,132) |
3,511,249 |
0 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • – |
2021-11-18 |
4 |
B |
$1.87 |
$5,610 |
D/D |
3,000 |
3,271,959 |
2.81 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
Director |
– • – |
2008-09-29 |
4 |
B |
$3.02 |
$6,040 |
D/D |
2,000 |
2,000 |
2.39 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • – |
2021-11-16 |
4 |
B |
$2.06 |
$6,180 |
D/D |
3,000 |
3,268,959 |
2.81 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • • |
2020-03-23 |
4 |
B |
$6.64 |
$6,640 |
D/D |
1,000 |
3,111,959 |
3.15 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • • |
2020-03-20 |
4 |
B |
$6.85 |
$6,850 |
D/D |
1,000 |
3,110,959 |
3.15 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • • |
2020-03-27 |
4 |
B |
$7.88 |
$7,880 |
D/D |
1,000 |
3,112,959 |
3.15 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • – |
2022-08-19 |
4 |
B |
$0.45 |
$9,098 |
D/D |
20,000 |
3,553,172 |
2.81 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • – |
2021-08-17 |
4 |
A |
$3.23 |
$9,690 |
D/D |
3,000 |
3,250,959 |
0 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
Director |
– • – |
2012-06-04 |
4 |
B |
$1.31 |
$10,480 |
D/D |
8,000 |
11,000 |
2.39 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • – |
2021-11-15 |
4 |
B |
$2.12 |
$10,600 |
D/D |
5,000 |
3,265,959 |
2.81 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • – |
2023-03-10 |
4 |
A |
$1.94 |
$10,707 |
D/D |
5,519 |
215,734 |
0 |
- |
|
| ATNX |
Athenex, Inc. |
CEO and Chairman of the Board |
• • • |
2020-09-11 |
4 |
B |
$10.91 |
$10,910 |
D/D |
1,000 |
3,142,959 |
3.15 |
- |
|
105 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
